Class II — Pulmonx, Corp.
| Recalling firm | Pulmonx, Corp. |
|---|---|
| Registered facility | PULMONX, Corp. (the firm's only registered facility) |
| Classification | Class II |
| Status | Ongoing |
| Reason | Endobronchial implant devices may have been labeled with a shortened expiration date but they can be used until the correct expiration date: 08 December 2024. |
| Product | Zephyr Endobronchial Valve (EBV) 5.5-LP, REF: EBV-TS-5.5-LP |
| Quantity | 144 |
| Distribution | US: TN, WV, AR, PA, VA, NC, IL, IA, MA, NY, NJ, WA, CO, OR, MI, FL, OH, TX, OK, AZ, NV, WI |
| Initiated | 2023-08-31 |
| Classified | 2023-11-06 |
| Recall number | Z-0235-2024 |
| Initiation | Voluntary: Firm initiated |
Source: U.S. FDA via openFDA (opens in a new tab) (device registration & enforcement). Data as of 2026-10-06. Verify this recall record at FDA → (opens in a new tab)
Cite this record
RegWarden. “Class II recall — Pulmonx, Corp. (Z-0235-2024).” Compiled from U.S. FDA public records (openFDA; FDA Data Dashboard). Data as of 2026-10-06. https://regwarden.com/recall/93179/
Alerts for Pulmonx, Corp.
Watchlist alerts will email you when FDA publishes a new recall, inspection classification, or warning letter for a facility you follow. They aren't open to the public yet — leave your email and we'll tell you when they are.
Want a one-page facility brief?
A single-page summary of this facility's registration and recall history for diligence. Not selling it yet — register interest and we'll follow up.